Table 1:
Univariate analysis of patient groups
| Outcome | Current Smoker | Previous Smoker | Never Smoker | Total | P Value |
|---|---|---|---|---|---|
| Major ipsilateral ischemic stroke | 3.4% (6/179) | 9.9% (11/111) | 4.3% (14/325) | 5.0% (31/615) | .043a |
| Major ipsilateral intracranial hemorrhage | 1.1% (2/179) | 3.6% (4/111) | 3.7% (12/325) | 2.9% (18/615) | .216 |
| Major morbidity | 4.5% (8/179) | 13.5% (15/111) | 8.0% (26/325) | 8.0% (49/615) | .024a |
| Neurologic mortality | 3.9% (7/179) | 4.5% (5/111) | 4.6% (15/325) | 4.4% (27/615) | .931 |
| Major morbidity and neurologic mortality | 7.3% (13/179) | 14.4% (16/111) | 10.5% (34/325) | 10.2% (63/615) | .146 |
| All-cause mortality | 4.5% (8/179) | 7.2% (8/111) | 5.2% (17/325) | 5.4% (33/615) | .564 |
| Complete aneurysm occlusion | |||||
| 180 days (−20/+42 days) | 75.0% (30/40) | 73.7% (28/38) | 76.1% (51/67) | 75.2% (109/145) | .969 |
| 1 yr (±42 days) | 96.9% (31/32) | 80.6% (25/31) | 80.9% (38/47) | 85.5% (94/110) | .068 |
| 3 yr | 95.2% (20/21) | 92.0% (23/25) | 93.3% (28/30) | 93.4% (71/76) | 1.000 |
| 5 yr | 94.1% (16/17) | 100.0% (19/19) | 92.3% (24/26) | 95.2% (59/62) | .615 |
| Last follow-up visit | 86.2% (50/58) | 79.6% (39/49) | 82.5% (80/97) | 82.8% (169/204) | .638 |
| In stent stenosis at last angiographic follow-up | |||||
| >50%–75% | 1.9% (1/52) | 2.2% (1/45) | 0.0% (0/81) | 1.1% (2/178) | .296 |
| >75% | 1.9% (1/52) | 0.0% (0/45) | 2.5% (2/81) | 1.7% (3/178) | .795 |
a
Significant.